Guoqing Li

Sales & Marketing chez Golden Maple Leaf Enterprises, Inc.

Health Technology

Consumer Services

Postes actifs de Guoqing Li

Sociétés	Poste	Début	Fin
Golden Maple Leaf Enterprises, Inc.	Sales & Marketing	27/07/2012	-
Golden Maple Leaf Enterprises, Inc.	Corporate Officer/Principal	23/05/2011	27/07/2012

Sociétés	Poste	Début	Fin
Welichem Biotech, Inc. Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.	Directeur/Membre du Conseil	21/10/2010	25/12/2012
	Président	25/12/2012	01/01/2016
	Independent Dir/Board Member	23/05/2011	01/01/2016

University of International Trade & Finance

Undergraduate Degree

Internationale

Canada	3
Chine	2

Opérationnelle

Director/Board Member	1
Chairman	1
Independent Dir/Board Member	1

Sectorielle

Health Technology	2
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Welichem Biotech, Inc. Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.	Health Technology
Golden Maple Leaf Enterprises, Inc.

Entreprise privées

Health Technology

Golden Maple Leaf Enterprises, Inc.